Read More

Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple oral drug candidates targeting inflammatory bowel disease.

AKTS